Literature DB >> 9018120

Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions.

F Kerangueven1, F Eisinger, T Noguchi, F Allione, V Wargniez, C Eng, G Padberg, C Theillet, J Jacquemier, M Longy, H Sobol, D Birnbaum.   

Abstract

To appreciate the involvement of known or potential susceptibility genes in sporadic breast tumors, we have searched for chromosomal deletions by studying loss of heterozygosity (LOH) at 43 microsatellite (CA)n markers from human chromosomes 10, 11 and 17, in 115 unselected consecutive samples of breast carcinoma with particular emphasis on specific regions. No site of consistent LOH was identified on chromosome 10. Five regions of LOH were contained within bands q22-24 of chromosome 11 for which nearly 50% of the tumors had LOH at at least one marker. This region is thus a major site of deletion in breast cancer and several tumor suppressor genes seem to be involved. One of them may be the ataxia telangiectasia (ATM) gene which is located in one of the affected regions. Five regions of LOH, one of which is within the BRCA1 gene area, were recognized along chromosome 17. LOH at three of these regions were found in highly proliferative tumors. When combined with a previous study of chromosome 13 with emphasis on BRCA2 and Rb1 genes, this work allowed to distinguish a total of 12 regions of LOH, variably affected in breast tumors and correlated with prognostic parameters.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9018120     DOI: 10.1038/sj.onc.1200818

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.

Authors:  H Ruffner; W Jiang; A G Craig; T Hunter; I M Verma
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.

Authors:  Satyabrata Sinha; Ratnesh K Singh; Nilanjana Bhattacharya; Nupur Mukherjee; Susmita Ghosh; Neyaz Alam; Anup Roy; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  Mol Oncol       Date:  2011-07-07       Impact factor: 6.603

3.  Genetically abnormal clones in histologically normal breast tissue.

Authors:  P S Larson; A de las Morenas; L A Cupples; K Huang; C L Rosenberg
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

4.  Elevated levels of somatic mutation in a manifesting BRCA1 mutation carrier.

Authors:  Stephen G Grant; Rubina Das; Christina M Cerceo; Wendy S Rubinstein; Jean J Latimer
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

5.  Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26.

Authors:  Ziad J Sahab; Michael D Hall; Lihua Zhang; Amrita K Cheema; Stephen W Byers
Journal:  J Cancer       Date:  2010-06-02       Impact factor: 4.207

6.  The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene.

Authors:  Eric S Martin; Rossano Cesari; Francesca Pentimalli; Kristine Yoder; Richard Fishel; Andrew L Himelstein; S Eric Martin; Andrew K Godwin; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

7.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.

Authors:  Brian J Miller; Daolong Wang; Ralf Krahe; Fred A Wright
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

8.  High Levels of Chromosomal Copy Number Alterations and TP53 Mutations Correlate with Poor Outcome in Younger Breast Cancer Patients.

Authors:  Ayla Koçak; Kerstin Heselmeyer-Haddad; Annette Lischka; Daniela Hirsch; David Fiedler; Yue Hu; Natalie Doberstein; Irianna Torres; Wei-Dong Chen; E Michael Gertz; Alejandro A Schäffer; Sandra Freitag-Wolf; Jutta Kirfel; Gert Auer; Jens K Habermann; Thomas Ried
Journal:  Am J Pathol       Date:  2020-05-13       Impact factor: 4.307

9.  Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: association with poor survival.

Authors:  M Gentile; K Olsen; M Dufmats; S Wingren
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

10.  European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium.

Authors:  V Launonen; K Laake; P Huusko; D Niederacher; M W Beckmann; R B Barkardottir; E K Geirsdottir; J Gudmundsson; P Rio; Y J Bignon; S Seitz; S Scherneck; I Bièche; M H Champème; D Birnbaum; G White; J Varley; M Sztán; E Olah; A Osorio; J Benitez; N Spurr; N Velikonja; B Peterlin; R Winqvist
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.